Category: CULTIVATION & RETAIL

Alliance Growers Reports State-of-the-Art Greenhouses and Proprietary CBD Strain

SHARE THIS POST March 5, 2018 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company is pleased to announce the addition of state-of-the-art greenhouses for year-round nurseries of cannabis plants for the production of a propriety CBD strain at the Company’s Cannabis Botany Centre. The initial roll out plans for up to 200,000 square feet of automated glass greenhouses with P.L. high-end horticultural lighting. The Alliance Growers’ greenhouses will be capable of producing over 300,000 grams per week or 15,600 kilograms per year of dried CBD cannabis. In a news release dated December 30, 2017, Alliance Growers announced that it has entered into a binding Letter of Intent (“LOI”) with WFS Pharmagreen Inc. (“Pharmagreen”), and its proposed subsidiary BC New Co, to create a strategic relationship, together with equity participation by Alliance and Pharmagreen, whereby Alliance will acquire a 30% equity interest in Pharmagreen’s subsidiary BC New Co. The execution of this LOI initiated the development of the Cannabis Botany Centre that Alliance and Pharmagreen have been working on for the past year. The state-of-the-art greenhouses will be a new addition to the Cannabis Botany Centre in Deroche, B.C. (located an hour and a half East of Vancouver) (the “Land”). The Land is a 25-acre property, where the 40,000 square foot plus Cannabis Botany Centre is being built to permit...

Read More

Maricann Provides Equity Financing Update

SHARE THIS POST Special Committee of Independent Directors Reviewing Trading Activity by Maricann Directors and Matters Involving its Chief Executive Officer Raymond Stone and Neil Tabatznik Resign As Directors Paul Pathak Appointed Interim Chairman of the Board TORONTO, Ontario, February 28, 2018 – Maricann Group Inc. (CSE:MARI, OTCQB:MRCCF, FRANKFURT:75M, “Maricann” or the “Company”) announced today that it has been advised orally by the underwriters that they are not prepared to proceed with the previously announced bought deal offering of 17,500,000 units of the Company, for gross proceeds of $70,000,000 (the “Offering”). The Company has not received an official notice of termination of the Offering. The Company also announces the resignations of Raymond Stone and Neil Tabatznik as directors and the appointment of Paul Pathak as interim chairman of the board. The Company also announced that the Ontario Securities Commission (“OSC”) has advised it that the OSC is conducting a review of the timing and reporting of certain trades in securities of the Company beneficially owned, directly or indirectly, or over which control or direction is exercised by Messrs. Stone and Tabatznik and Eric Silver or their respective associates and affiliates or by other persons otherwise directly or indirectly related to them, as the case may be, that were effected prior to the announcement of the Offering. Messrs. Stone, Tabatznik and Silver have advised the Company that they are fully...

Read More

Harvest One Launches Retail Platform and Completes Initial Sales

SHARE THIS POST VANCOUVER, Feb. 28, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV:HVT) (“Harvest One” or the “Company”) through its wholly-owned subsidiary United Greeneries (“United Greeneries” or “UG”) is pleased to announce the launch of its retail platform and initial sales of their two brands Royal High and Captain’s Choice. As previously announced on January 8, 2018, United Greeneries has launched medical sales in February 2018. The fully developed branding was released earlier this week and the fully functional e-commerce platform is currently online. Please visit United Greeneries website at www.unitedgreeneries.com for further information on our products. Captain’s Choice™ United Greeneries signature product line Captain’s Choice™ consists of blended, high-quality ground flowers. Captain’s Choice™ will be available in the varieties “Indica”, “Sativa” and “High-CBD”. United Greeneries’ specialized blending and grinding process results in consistent product quality and reduced production costs that the Company will be passing on to its customers. Royal High™ The Company’s premium brand Royal High™ will feature prime quality full cannabis flowers of selected varieties, initially consisting of Serious Kush, Great White Shark, Super Skunk, 8 Ball Kush, CBD Tonic, Serious Kush, Northern Lights and Chocolope. Several other varieties are currently in production. About Harvest One Cannabis Inc. (TSXV: HVT) Harvest One is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders...

Read More

ABcann Global Completes $70 Million Bought Deal Financing and $4.8 Million Exercise of Underwriters’ Over-Allotment Option

SHARE THIS POST NAPANEE, Ontario, Feb. 28, 2018 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”) is pleased to announce that it has closed its bought deal financing, as previously announced on January 29, 2018, of: (i) 11,500,000 units (each, a “Unit”) of the Company at a price of $3.50 per Unit, for aggregate gross proceeds of $40,250,000 (the “Unit Offering”); and (ii) 30,000 6.0% unsecured convertible debentures (each, a “Convertible Debenture”) of the Company at a price of $1,000 per Convertible Debenture, for aggregate gross proceeds of $30,000,000 (the “Debenture Offering” and collectively with the Unit Offering, the “Offering”). The Offering was conducted by a syndicate of underwriters led by Canaccord Genuity Corp. and Eight Capital and including GMP Securities L.P. and PI Financial Corp. (collectively, the “Underwriters”). In addition, the Offering included 862,500 Warrants (defined below) and 4,500 Convertible Debentures sold pursuant to the exercise of the Underwriters’ over-allotment option, for additional aggregate gross proceeds of $4,793,250. “Completion of the Offering further increases our cash position to over $135 million and will allow us to pursue multiple opportunities and execute our strategic vision,” stated Barry Fishman, ABcann’s Chief Executive Officer.The Units and the Convertible Debentures were offered by way of a short form prospectus (the “Prospectus”) in all provinces of Canada except Quebec. The net proceeds of the Offering will be used for the...

Read More

Valens GroWorks Enters into LOI with Ross’ GoldTM

SHARE THIS POST Vancouver, B.C., February 28, 2018 –Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multilicenced, vertically integrated provider of cannabis products, is pleased to announce entering into a Letter of Intent for the purchase of a 19.9% interest in R Gold Venture Inc., doing business as Ross’ GoldTM (“Ross’ Gold”), a privately-held corporation with multi-location cannabis retail stores through franchising, with a full line of premium lifestyle consumables and hard goods. Through this initial purchase Valens establishes a presence into the opening retail recreational cannabis market by collaborating with a robust lifestyle brand and retail model. Ross’ Gold is one of Canada’s most well-established cannabis brands with a talented and diverse team. The Ross’ Gold team includes industry leaders with strong cannabis backgrounds who have made significant strides in growing their national retail footprint. Ross Rebagliati, Ross’ Gold’s brand ambassador, commented, “Ross’ Gold is excited about the partnership with Valens and their versatile team. Ross’ Gold is a premium lifestyle brand recognized nationally and abroad. Our key focus is to make a presence in Canada with our retail operators through building out inviting and upscale retail storefronts catering to the diverse adult recreational consumer market.” “This is a significant step for Valens to become a prominent vertically integrated brand house” said Tyler Robson, Valens’ CEO. “I’m proud to be working with one of the strongest...

Read More

MYM Announces Closing of Non-Brokered Financing

SHARE THIS POST Vancouver, B.C., February 27, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce it has closed its non-brokered private placement of 535,319 units at a price of $2.25 per unit for gross proceeds of $1,204,467.75 (the “Private Placement”). Insiders subscribed to 100,443 units for gross proceeds of $225,996.75. As a result, the Private Placement is considered to be a “related party transaction” as defined under Multilateral Instrument 61-101 (“MI 61-101”). The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of any shares issued to or the consideration paid by such persons exceeded 25% of the Company’s market capitalization. No commissions were paid in respect to the Private Placement. Each unit in the Private Placement is comprised of one common share and one transferable share purchase warrant, with each warrant exercisable into one additional common share at a price of $3.25 for a period of two years. The warrants are subject to acceleration in certain circumstances. The securities will be subject to a four-month-and-one-day hold period under securities laws. The Company intends to use the net proceeds from the private placement for general working capital and corporate purposes. About MYM Nutraceuticals Inc. MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and...

Read More